MedTrace Logo

Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation

NCT01182155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-07-01

No results posted yet for this study

Summary

Patients treated with radiation therapy for lung tumors can experience inflammation after treatment. This study hopes to evaluate the use of breath analysis to evaluate changes in the composition of exhaled breath in patients undergoing radiotherapy. If changes can be detected, this may ultimately serve as biomarkers for identifying patients at highest risk for radiation-induced lung injury (radiation pneumonitis).

Conditions

Interventions

PROCEDURE

Exhaled Breath Sampling

Standard of care

Sponsors & Collaborators

Principal Investigators

  • Dr. Maximilian Diehn MD/PhD · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-09-30
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01182155 on ClinicalTrials.gov